Abiopharma

🔍 Graham-Cumming John (Director)

Company: Cloudflare, Inc. (NET)

Report Date: 2026-06-15

Detailed Transactions and Holdings:

• Acquired 2,520 shares of Class A Common Stock at $44.72 per share (Direct)
  Date: 2026-06-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 496,587.00 | transaction_form_type: 4
• Sold 44 shares of Class A Common Stock at $231.6005 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 496,543.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 144 shares of Class A Common Stock at $233.4633 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 496,399.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 748 shares of Class A Common Stock at $234.7992 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 495,651.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 596 shares of Class A Common Stock at $235.7474 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 495,055.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 430 shares of Class A Common Stock at $236.7593 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 494,625.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 504 shares of Class A Common Stock at $238.0236 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 494,121.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 54 shares of Class A Common Stock at $238.5189 per share (Direct)
  Date: 2026-06-15 | Code: S | equity_swap_involved: 0 | shares_owned_after: 494,067.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 2,520 shares of Stock Option (right to buy) at $44.72 per share (Derivative)
  Date: 2026-06-15 | Code: M | Expires: 2032-02-13 | equity_swap_involved: 0 | shares_owned_after: 5,040.00 | transaction_form_type: 4 | Footnotes: F9

Footnotes:

• F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.58 to $231.625, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (8) to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.145 to $233.97, inclusive.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.29 to $235.27, inclusive.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.30 to $236.29, inclusive.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.335 to $237.265, inclusive.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.485 to $238.44, inclusive.
• F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.49 to $238.615, inclusive.
• F9: Shares subject to the option are fully vested and immediately exercisable.
• REMARKS: Exhibit 24 - Power of Attorney